SCHEMBL6969576

SCHEMBL6969576

CCOc1cccc(Nc2ccnc(Cl)n2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.54
ROCK1 Q13464 3/20 0.53
ROCK2 O75116 1/20 0.53
PRKACA P17612 1/20 0.53
PRKCD Q05655 1/20 0.53
DYRK1A Q13627 1/20 0.53
CDC42BPA Q5VT25 1/20 0.53
SYK P43405 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
PTK6 Q13882 1/20 0.48
HTR3E A5X5Y0 1/20 0.47
HTR3B O95264 1/20 0.47
HTR3A P46098 1/20 0.47
HTR3D Q70Z44 1/20 0.47
HTR3C Q8WXA8 1/20 0.47
IGF1R P08069 3/20 0.45
ERBB3 P21860 1/20 0.44
TSHR P16473 1/20 0.43
BRD4 O60885 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6978657 0.86 EGFR (0.72) EGFRROCK1MEN1KMT2AIGF1R
SCHEMBL2064243 0.83 ROCK1 (0.56) EGFRROCK1ROCK2PRKACAPRKCD
SCHEMBL655624 0.83 SYK (0.53) EGFRROCK1ROCK2PRKACAPRKCD
SCHEMBL14368038 0.81 ROCK1 (0.49) EGFRROCK1SYKHTR3EHTR3B
SCHEMBL6980608 0.80 IGF1R (0.60) EGFRROCK1ROCK2PRKACAPRKCD
SCHEMBL13166085 0.79 NFKB1 (0.58) EGFRROCK1ROCK2DYRK1ACDC42BPA
SCHEMBL3211816 0.78 HTR3E (0.72) EGFRROCK1PRKCDSYKHTR3E
SCHEMBL17526260 0.77 BRD4 (0.60) EGFRSYKMEN1KMT2ATSHR
SCHEMBL11518974 0.77 SYK (0.57) SYKMEN1KMT2APTK6TSHR
SCHEMBL7082129 0.77 EGFR (0.62) EGFRROCK1ROCK2PRKACAPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0862560-B1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LTD (GB) 2003-04-02 EP disclosed
US-6235746-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATIVE AGENT CELLTECH THERAPEUTICS, LIMITED (GB) 2001-05-22 US disclosed
US-5958935-A Substituted 2-anilinopyrimidines useful as protein kinase inhibitors CELLTECH THERAPEUTICS LIMITED (GB) 1999-09-28 US disclosed
EP-0862560-A1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1998-09-09 EP disclosed
WO-1997019065-A1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1997-05-29 WO disclosed